HomeAPS • TSE
add
Aptose Biosciences Inc
Previous close
$0.27
Day range
$0.24 - $0.26
Year range
$0.19 - $3.48
Market cap
3.95M CAD
Avg Volume
35.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.96M | -40.37% |
Net income | -6.95M | 39.26% |
Net profit margin | — | — |
Earnings per share | -0.37 | 78.98% |
EBITDA | -6.96M | 40.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.96M | -55.06% |
Total assets | 10.93M | -47.65% |
Total liabilities | 20.06M | 53.15% |
Total equity | -9.13M | — |
Shares outstanding | 19.52M | — |
Price to book | -0.56 | — |
Return on assets | -159.18% | — |
Return on capital | -15,207.42% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.95M | 39.26% |
Cash from operations | -10.38M | 1.52% |
Cash from investing | — | — |
Cash from financing | 10.01M | 104.16% |
Net change in cash | -368.00K | -105.03% |
Free cash flow | -7.68M | -24.12% |
About
Founded
1986
Headquarters
Website
Employees
36
